08/08/2024
Let's take a minute to celebrate the success of lenacapavir. That's an antiviral for the treatment and prevention of HIV, and when it was approved in 2022 it was the first capsid inhibitor to reach the market. There are a lot of antiviral mechanisms out there (and specifically quite a few directed a...